Last update 27 Dec 2024
Ariceum Therapeutics GmbH

Ariceum Therapeutics GmbH

Startups
|
Holding Company|
2021|
Germany
|
10-50
|

Overview

Basic Info

Introduction
Established in 2021 and headquartered in Berlin, Germany, Ariceum Therapeutics GmbH is a biotechnology company with operations across Europe, North America and Australia, as well as an operational base in the UK. The company focuses on the development of radiopharmaceutical products, with its main product, the 177Lu-satoreotide tetraxetan or "satoreotide", designed for the diagnosis and targeted radioactive treatment of neuroendocrine tumours (NETs) and certain aggressive cancers like SST2 and small cell lung cancer (SCLC), all of which have limited treatment options and poor prognosis.

Tags

Neoplasms
Respiratory Diseases
Therapeutic radiopharmaceuticals
Peptide Conjugate Radionuclide
Diagnostic radiopharmaceuticals

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug5
Diagnostic radiopharmaceuticals5
Therapeutic radiopharmaceuticals3
Peptide Conjugate Radionuclide2
Radionuclide Drug Conjugates (RDC)1

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 27 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
3
4
Phase 1
Phase 2
1
1
Approved
Other
1
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free